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Abstract: To show the efficacy of double-balloon cervical ripening catheter in the   management 
of postpartum hemorrhage originating from the lower segment of the uterus or the upper parts 
of the vagina.
Methods: Patients with intractable bleeding from the lower segment of the uterus and the 
upper parts of the vagina after Cesarean or vaginal deliveries were treated by double-balloon 
cervical ripening catheter.
Results: Double-balloon catheter was used in seven patients, and it was properly placed in all 
of them. No other intervention was needed to control bleeding. Two patients were delivered 
vaginally, and five patients were delivered by Cesarean section. Length of hospitalization was 
longer in the vaginal delivery patients (average hospitalization was 12 days in the vaginal delivery 
patients and 5 days in the Cesarean section patients). The need for blood and blood products 
  transfusion (average of blood and blood products transfusion was 30 U in the vaginal delivery 
patients and 6 U in the Cesarean patients) was also higher in the vaginal delivery patients.
Conclusion: Although double-balloon cervical ripening catheter is designed for the induction 
of labor, it can successfully control intractable bleedings from the lower segment of the uterus 
and the upper parts of the vagina. This procedure can save patients from undergoing more 
morbid procedures.
Keywords: cesarean section, double-balloon catheter, postpartum hemorrhage, vaginal 
delivery
Introduction
Postpartum hemorrhage (PPH) is a common complication of delivery. No consensus 
about its definition is available; however, blood loss from any part of the genital tract 
greater than 500 mL after vaginal delivery and blood loss greater than 1,000 mL after 
Cesarean delivery can be classified as PPH.1
The cause of hemorrhage must be distinguished correctly to decide the treatment 
method. Uterine atony, placenta retention, and lacerations of the genital tractus are 
the most common causes.2 As soon as the PPH is observed, treatment options should 
be applied step by step. If medical treatment fails, conservative methods or surgery 
are indicated.
The morbidity and mortality of surgical methods are high; therefore, new 
  conservative methods are developed to control the bleeding, including balloon 
  tamponate and arterial embolization. These conservative methods are very important, 
because most of the intractable bleedings can be successfully treated and hysterectomy 
can be avoided.3 These methods are also more important especially for patients who 
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Different types of balloons are used to make the   uterine 
tamponade, according to the cause of PPH. After the deliv-
ery of the baby and the placenta, contraction of muscle 
fibers seals the blood vessels. Because of the low density of 
muscle fibers in the cervix, control of the bleeding can be 
more difficult. A balloon exerting pressure from both sides 
may be more efficient to control bleeding from the lower 
parts of the uterus.
We herein report a serious case of PPH, originating 
from the lower segments of the uterus and upper parts of 
the vagina that was successfully controlled with a double-
balloon catheter.
Materials and methods
Cases with PPH that were unresponsive to medical   treatment 
were managed with the cervical ripening balloon cath-
eter in Firat University, Faculty of Medicine, Department 
of   Obstetrics and Gynecology, between January 2012– 
August 2013. In this period, 2,164 deliveries occured. Their 
records were analyzed retrospectively. In the statistical 
analysis of the data, SPSS 21.0 program (IBM Corporation, 
Armonk, NY, USA) and descriptive statistics were used. The 
adopted protocol was approved by the hospital research and 
ethics committee.
Bleeding of more than 1,000 mL that is unresponsive to 
routine management is named PPH. There were two groups 
of patients. The first group included patients who underwent 
vaginal delivery and showed uncontrolled bleeding from 
the cervix and upper parts of the vagina. The second group 
included patients who underwent a Cesarean section due to 
placenta previa and showed intractable bleeding from the 
lower segments of the uterus that was resistant to medi-
cal treatment. The lower segment remained floppy and not 
contracted. Diagnosis of placenta previa was confirmed 
before the operations by transvaginal ultrasound. In the vagi-
nal delivery group, patients were referred from other hospitals 
with massive bleeding and a near collapse of the circulation 
after delivery. They were immediately taken to the operat-
ing room. Blood circulation and oxygenation were restored. 
Uterotonics were continued; the uterus was contracted. 
A pelvic examination was done under general anesthesia, 
and lacerations were repaired, if possible. Bleeding contin-
ued even from the beds of the suture, or suture could not be 
applied because of the fragile and edematous consistency 
of the tissues. We decided to apply a double-balloon cervi-
cal ripening catheter made of silicone material (maximum 
capacity 80 mL, tested top capacity 250 mL; Cook Medical, 
Bloomington, IN, USA,) to control bleeding (Figure 1). 
Ring forceps were used to insert the catheter under direct 
examination of the cervix. The uterine portion of the bal-
loon was inflated with an 80–110 mL saline solution. Then, 
a gentle traction was applied to fit the balloon firmly to the 
cervical portion of the uterus. The vaginal portion was then 
inflated with another 80 mL (Figure 2). The position of the 
balloons was reevaluated by ultrasonography. In the Cesarean 
section, the catheter was also inserted vaginally and, after the 
repair of the uterine incision by using polyglactic acid No 
1-0 (Laktasorb, Boz, Istanbul, Turkey), it was inflated by an 
Figure 2 MRi image of cervical ripening catheter in Cesarean section patient.
Notes: Inflated cervical ripening balloon involving cervix and proximal vagina. sagittal 
T2-weighted MRI demonstrates inflated cervical ripening balloon transversing internal 
cervical os (thin arrow). Proximal portion of inflated balloon (arrowhead) is localized 
in the cervix. Distal portion of the balloon (thick arrow) is localized in vagina.
Abbreviation: MRi, magnetic resonance imaging.
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assistant vaginally in the same manner. All of the catheters 
were placed successfully, and in all of the patients, the bal-
loon tamponate worked well.
A marked decrease of the bleeding was observed before 
the end of the operation. The balloon tamponates were kept 
inflated for 2 days with careful monitoring of the vital signs 
and bleeding. The balloons were deflated gradually at a rate 
of 40 mL for each balloon every hour; blood leakage was 
controlled by pads during the deflation period. Broad spec-
trum antibiotics were given for five days to all patients.
In the Cesarean section group, 5 U/mL oxytocin   (Synpitan 
forte® ampule, 5 IU; Deva, Istanbul, Turkey) was given as a 
bolus, following the delivery of the fetus and 0.5 mg methyl 
ergonovine maleate (Methergine® ampule, 0.2 mg; Sandoz 
Inc., Wilson, NC, USA) was administered as a bolus, follow-
ing the delivery of the placenta. Also, 20 U/L of oxytocin was 
infused in a 1 L solution and then given as 250 mL/hour in all 
patients during the operation and in the first 6 hours postop-
eratively. Also, 600 µg rectal misoprostol was administered to 
control bleeding. The urine flow and vital signs were recorded 
every 15 minutes for the first 2 hours and every hour for the 
other 6 hours. Methylergonovine maleate was given every 8 
hours in all patients except the one with preeclampsia.
The postoperative blood loss was calculated by weighing 
the pads used by the patients, and no major bleeding was 
detected. Descriptive statistics were used.
The age of the patients, gestational age, mode of deliv-
ery, gravidity, parity, birth weight, preoperative and post-
operative hemoglobin and hematocrit values, the amount 
of   transfusions of blood and blood products, risk factors 
for PPH, length of hospitalization, and adverse events are 
shown in Table 1.
Results
A double-balloon catheter was used in seven patients, and it 
was properly placed in all of them. Bleeding was successfully 
controlled, and no other intervention was needed. None of the 
patients had placental invasion anomalies. Preeclampsia was 
present in one of the patients, and massive bleeding caused 
a coagulation abnormality in one of the patients. These two 
patients were delivered vaginally. No other systemic or 
medical disease was present.
The median age of the patients was 30 with a range of 
16–41 years old. Gestational age was between 35–39 weeks; 
median gestational age was 37 weeks. Two patients were 
nulliparous, and five were multiparous. Five of the PPH fol-
lowed Cesarean delivery, and the other two followed vaginal 
delivery. Birth weight ranged between 2,520–4,160 g; median 
birth weight was 3,080 g. No congenital anomaly was pres-
ent. All of the patients needed transfusions, but it was much 
more in the vaginal delivery patients transferred from other 
centers after delivery. In one patient, disseminated intravas-
cular coagulation occured. She was taken to the intensive 
care unit after the operation and was monitored in this unit 
for 5 days.
The average blood/blood products’ transfusion amount was 
30 U in the vaginal delivery patients and 6 U in the   Cesarean 
section patients. The average length of hospitalization was 
Table 1 Obstetric and clinical characteristics of the cases
Parameters Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7
Maternal age (year)/ 
gestational age (week)
41/39 16/38 34/35 30/37 35/36 29/37 28/36
G (number)/P (number)/ 
a (number)
4/3/0 1/  0/0 3/2/0 8/1/6 2/0/1 3/2/0 2/1/0
Risk factor advanced  
maternal age
Preeclampsia Placenta previa 
totalis
Placenta previa 
totalis
Placenta previa 
totalis
Placenta previa 
totalis
Placenta previa 
totalis
Mode of delivery Vaginal Vaginal Cesarean  
section
Cesarean  
section
Cesarean  
section
Cesarean  
section
Cesarean 
section
Weight of baby (gram) 3,200 3,000 2,520 4,160 3,150 3,080 2,950
Preoperative Hb (g/dL)/Htc (%) 8.4/24.6 8.1/25.3 7.3/23.6 13.1/37.4 13.4/37.6 12.1/35.3 11.4/33.1
Postoperative 1 day 7.4/21.1 7.2/20.3 9.1/26.4 10.1/31.2 11.6/33.2 10.1/31.2 9.3/27.4
Postoperative 3 day Hb (g/dL)/ 
Htc (%)
8.9/25.2 11.1/32.4 8.8/26.3 9.3/27.5 9.8/30.1 9.8/27.6 9.1/26.0
Red cell concentrate (unit) 20 7 3 3 3 3 3
FFP (unit) 20 7 3 3 2 3 3
Whole blood (unit) 6  – 1 – – – –
adverse event DiC – – – – – –
Length of hospitalization (days) 17 7 6 4 5 4 4
Abbreviations: G, gravida; P, parity; a, abortus; Hb, hemoglobin; Htc, hematocrit; FFP, fresh frozen plasma; DiC, disseminated intravascular coagulation.Therapeutics and Clinical Risk Management 2014:10 submit your manuscript | www.dovepress.com
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12 days in the vaginal delivery patients and 5 days in the 
Cesarean section patients.
The cases of patients who were bleeding after vaginal 
delivery were referred from another hospital. One lost 
  consciousness; the other one was confused at admittance. 
Blood pressure could not be taken. The pulse was thready in 
the first one and blood pressure was 50/40 mmHg and pulse 
was 124/minutes in the second one.
The other five patients were referred to our hospital with 
the diagnosis of placenta previa totalis. Two patients had 
two cesarean section history, the other two patients had one 
cesarean section and the last patient was nulliparous. All of 
these five patients underwent a Cesarean section and, after 
the removal of placenta, bleeding continued from the pla-
cental bed. We applied the double-balloon catheter to all and 
inflated the uterine part with a 0.9% saline solution, ranging 
from 80–110 mL and the vaginal part with 80 mL, since the 
contraction of the uterus was sufficient. The uterine portion 
of the double balloon successfully filled the lower segment 
of the uterus. The hemodynamic status of the patients in the 
Cesarean section patients did not deteriorate, because bal-
loons were applied in a short time.
Discussion
After the delivery, the muscles of all parts of the uterus con-
tract rapidly to limit bleeding. Some deliveries can be com-
plicated with life-threatening heavy bleeding if the muscles 
of any part of the uterus – more commonly the cervix or the 
whole uterus – do not contract early, rapidly, and strongly 
enough. Any laceration in the genital tractus also causes 
such a massive bleeding. Maternal mortality due to PPH is 
about 100 times higher in resource-poor countries than in 
resource-rich ones.4
Delivery is a process that occurs in every part of the world. 
It is not possible for a country to gather all the   deliveries to 
special well-equipped centers. Since it is known that eti-
ologies causing PPH in the first 24 hours of delivery cause 
greater blood loss and morbidity, PPH must be treated rapidly 
and – if possible – in the same place as delivery without 
transfer of the patient.5
Because of these reasons, measures that are safe,   effective, 
easily applicable in every unit are very important in the   control 
of PPH. In the past, when uterine massage, administration 
of uterotonics, curettage and repair of lacerations failed to 
control massive bleeding, surgical interventions including 
laparotomy with uterine, utero-ovarian or hypogastric artery 
ligation, or even hysterectomy were considered. But all 
these surgical approaches have some morbidities and also 
need an experienced team and equipment. Hysterectomy is 
a traumatic option to control bleeding in women who desire 
to preserve their fertility. So other conservative treatment 
options, including intrauterine tamponate and uterine artery 
embolization, have been developed. Although uterine artery 
embolization is an important modality in the management 
of PPH and can avoid patients undergoing surgery, it needs 
equipment and an experienced team.
Uterine tamponate can be applied by balloons. Balloons 
are inflated to a volume at which it can exert a pressure that 
is greater than the systemic arterial pressure to uterine wall. 
It is believed that pressure greater than systemic arterial 
pressure applied to the uterine wall by the inflated balloon is 
the mechanism of controlling the hemorrhage. This pressure 
can be achieved by inflating different balloons by different 
volumes.6
Balloon tamponates in general are procedures that can be 
applied in the delivery room even by inexperienced operators 
or midwives. This makes it an important step in the treatment 
of PPH. It is a safe procedure, and its effect starts as soon 
as the balloon is inflated. By stopping the hemorrhage 
promptly, consumptive coagulopathy can be inhibited. This 
procedure is less invasive than surgical intervention. It can 
be available in all maternal wards. The availability of the 
application of the balloon tamponate in the delivery room is 
very important, because a patient with uncontrolled bleeding 
cannot be transferred to another center; transfer can make 
the prognosis worse.7
In our study, two cases were transferred after delivery 
from other centers in our city and their hemodynamic status 
was unstable at the arrival to our hospital. The need for blood 
transfusion and the length of hospitalization were longer in 
these patients. Even in cases with failure, the balloon can also 
temporarily tamponate the bleeding sites and give the chance 
of transfer without deterioration of the patient. Laparotomy 
and hysterectomy can be avoided in many cases.
Different types of balloon tamponates have been used 
in the last decades to control postpartum hemorrhage, such 
as the Sengstaken–Blakemore tube, Foley catheter, Rusch 
catheter, Bakri catheter, or the simple Foley condom.8 
Success of the balloon tamponate also differs according to 
the cause of the PPH.
In one study, the catheter placement controlled PPH 
originating from uterine atony in 100% of cases, but it was 
successful in only 80% of patients with retained placenta.9 
In another study, the Bakri balloon tamponate was used to 
control PPH due to a cervical rupture where the surgical 
repair did not work. The Bakri balloon was either inserted Therapeutics and Clinical Risk Management 2014:10 submit your manuscript | www.dovepress.com
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into the lower uterine segment or the vagina. It worked well 
in six patients among seven, and bilateral artery ligation was 
needed in one case.10
The success rate of the balloon tamponate varies between 
77.5%–88.8%. This means that approximately among 
five PPH cases, four can be treated by balloons without 
undergoing a surgical intervention that has a high morbidity 
rate. Balloon tamponate can also effectively control bleeding 
in the cases of placenta accreta, amniotic fluid embolism, 
septic shock with disseminated intravascular coagulation, 
and retained placenta.9
In the literature, the double-balloon cervical ripening 
catheter was successfully used to control severe postabortion 
hemorrhage.11 Since maternal mortality is more common in 
poor countries, such conventional methods that do not need 
well-equipped hospitals and an experienced team become 
more important. We believe that by widely and effectively 
using these methods, maternal mortality can be reduced to a 
great extent. All the health care staff – including midwives – 
must be aware of the benefits of these balloon catheters and 
must be able to use them. Special balloons must be designed 
and distributed to all delivery units all over the world.
The ideal balloon must be flexible, soft, and of a 
  nontraumatic consistency to reduce the risk of perforation. 
Its application must be easy, so that it can be used by all 
operators. It must be quickly applied, because a few minutes 
of lost time may cause prominent blood loss. It must be cheap 
to be widely usable. It must have a drainage part to calcu-
late correctly the blood loss and to prevent blood   collection 
inside the uterine cavity. Direct visualization of the blood 
loss also helps us to determine the patients in which the 
procedure fails. Its shape must be compatible to the shape 
of the application area.
The only known contraindication of the balloon is 
  postpartum infection. In patients with a rubber/latex allergy, 
the balloon must be chosen accordingly. The application of 
the balloon tamponate can be unsuccessful in some cases 
due to different causes, such as the obstruction of the cervix 
by leiomyoma.9 Few studies report difficulties or failures in 
using the balloons. Some of these failures may be interpreted 
as complications of placement.9,12 The potential advantage 
of this double-balloon cervical ripening catheter probably 
originates from the pressure applied from both sides of the 
cervix. It can also apply pressure to the upper parts of the 
vaginal wall.
We first used this balloon in a PPH patient who underwent 
Cesarean section due to placenta previa, and the Bakri bal-
loon could not be passed from the cervix because of its large 
  diameter. After the observation of its efficacy, we decided 
to try it in other cases. It worked well in all patients, and 
no other interventions were needed. We believe that the 
double-balloon tamponate can effectively control bleed-
ing that originates from the lower parts of the uterus and 
the upper parts of the vagina. We advise the usage of the 
double-balloon cervical ripening catheter to stop bleeding 
from the lower parts of the uterus, but the Bakri balloon is 
more appropriate for uterine atony due to its large diameter. 
Also, the double-balloon catheter can be preferred – as in 
our first case – when the cervix is so small that the Bakri 
balloon cannot be inserted from the cervix. By sharing our 
experiences all over the world about the different balloon 
types, we believe that the ideal balloon can be designed more 
easily, and the operators can be encouraged to use them 
before performing a surgical procedure in PPH resulting 
from different causes.
One restrictive property of our study was the low number 
of cases. Further studies must be made with a high number of 
patients and the best volume of balloon inflation required to 
stop hemorrhage, the most appropriate duration of   application 
and the type of balloon for different indications must be 
determined.
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